Geode Capital Management LLC Increases Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Geode Capital Management LLC boosted its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.9% in the third quarter, Holdings Channel.com reports. The firm owned 1,613,198 shares of the company’s stock after acquiring an additional 14,197 shares during the quarter. Geode Capital Management LLC’s holdings in Acadia Healthcare were worth $102,320,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ACHC. Wellington Management Group LLP grew its stake in shares of Acadia Healthcare by 12.2% during the 3rd quarter. Wellington Management Group LLP now owns 11,658,253 shares of the company’s stock valued at $739,250,000 after buying an additional 1,266,384 shares during the period. William Blair Investment Management LLC boosted its holdings in Acadia Healthcare by 20.7% in the second quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock valued at $237,434,000 after acquiring an additional 604,070 shares during the last quarter. State Street Corp grew its position in Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after acquiring an additional 95,613 shares during the period. Point72 Asset Management L.P. increased its stake in Acadia Healthcare by 0.5% during the third quarter. Point72 Asset Management L.P. now owns 2,282,810 shares of the company’s stock worth $144,753,000 after acquiring an additional 12,470 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in shares of Acadia Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after purchasing an additional 77,509 shares during the period.

Acadia Healthcare Trading Down 1.5 %

ACHC opened at $39.05 on Thursday. The stock has a market capitalization of $3.63 billion, a PE ratio of 12.80, a P/E/G ratio of 1.77 and a beta of 1.29. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a 12-month low of $36.50 and a 12-month high of $87.77. The firm’s fifty day moving average price is $44.48 and its 200 day moving average price is $61.24.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The business had revenue of $815.60 million for the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.91 EPS. As a group, research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Royal Bank of Canada dropped their target price on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a research report on Monday, November 18th. Cantor Fitzgerald reissued a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Barclays decreased their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a research report on Friday, November 22nd. KeyCorp initiated coverage on Acadia Healthcare in a research report on Friday, October 11th. They issued a “sector weight” rating on the stock. Finally, StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, November 22nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. According to MarketBeat, Acadia Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.